Position 
Associate Professor 

Qualifications
MSc (Dhaka) PhD (Lond) DIC DipEd MCAE

Dr Fazlul Huq teaches toxicology, biochemistry and biophysics to students in the
Faculty of Health Sciences.

Dr Huq also enjoys writing poetry in his spare time.  If you are interested in reading
some of his work, download the pdf files below:

• Complexity
• Inspiration
• Sweet Home
• The Swan Lake
• Apoptosis
• Breast Cancer
• Ovarian Cancer
• Cancer Pathways
• Carbon Footprint
• Consciousness
• The H-Bond
• The Signs
• The Struggle to Survive
• Membrane
• Cisplatin
• Periodic Table
• Rendevouz
• Antioxidants

Research

Dr. Fazlul Huq is an internationally recognized researcher on metal-based anticancer drugs, metal-based carcinogenicity and toxicity, and drug metabolism. His group has designed a number of rule-breaker platinum-based tumour active compounds. He has carried out a significant number of molecular modeling analysis of drug metabolism.

Dr. Fazlul Huq is a bioinorganic cum medicinal chemist and a toxicologist with substantial experience in metal-induced toxicity and carcinogenicity, drug metabolism and design of novel platinum-based anticancer drugs some with great potential for development as novel anticancer drugs. His group demonstrated that replacement of the central platinum unit in the trinuclear platinum complex BBR3464 (that is currently under development as an anticancer drug) with other suitable metal units would also result into highly tumour active compounds. In addition, he showed that the incorporation of bulky planaramine ligands bonded to the central metal unit would introduce additional types of non-covalent interactions that can modulate activity. His group also synthesized some trans-planaramineplatinum(II) complexes having high cell uptake and high level of binding with cellular DNA but with little or no activity. He has over 140 publications in peer-reviewed journals.

During the last eight years, he has supervised seven PhD and 5 Master candidatures to successful completion.
The following list gives Dr. Huq's recent publications on:-

Anticancer drugs and carcinogenicity
Xenobiotics metabolism
Fundamental chemistry and others

Recent publications

1. Huq F (2001), Molecular modeling analysis of the ease in oxidation of planar nickel-peptide complexes, J Mol Model, 7(12), 433-437.
2. Huq F and Yu JQ (2002), Molecular modeling analysis: “Why is 2-hydroxypyridine soluble in water but 3-hydroxypyridine is not?”, J Mol Model, 8(3), 81-86.
3. Hossain Z and Huq F (2002), Studies on the interaction between Cd2+ ions and nucleobases and nucleotides, J Inorg Biochem, 90: 85-96.
4. Hossain Z and Huq F (2002), Studies on the interaction between Cd2+ ions and DNA J Inorg Biochem, 90: 97-105.
5. Hossain Z and Huq F (2002) Studies on the interaction between Ag+ and DNA, J Inorg Biochem, 91: 398-404.
6. Huq F, Yu JQ, Daghriri H, Beale P (2004) Studies on activities, cell uptake and DNA binding of four trans-planaramineplatinum(II) complexes of the form: trans-PtL(NH3)Cl2 where L = 2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2-a)pyridine, J Inorg Biochem 98, 1261-1270.
7. Huq F, Daghriri H, Yu JQ, Beale P and Fisher K (2004) Studies on the synthesis and characterization of four trans-planaramineplatinum(II) complexes of the form trans-PtL(NH3)Cl2 where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-a)pyridine, Eur J Med Chem, 39/8, 691-697.
8. Huq F, Daghriri H, Yu JQ, Tayyem H, Beale P and Zhang M (2004) Synthesis, characterisation, activities, cell up take and DNA binding of [{trans-PtCl(NH3)2}{m-(H2N(CH2)6NH2)}{trans-PdCl(NH3)2](NO3)Cl, Eur J Med Chem, 39/11, 947-958.
9. Daghriri H, Huq F, Beale P (2004) Studies on activities, cell up take and DNA binding of four multinuclear complexes of the form: [{trans-PtCl(NH3)2}2{m-trans-Pd(NH3)2-(H2N(CH2)nNH2)2]Cl4 where n = 4 to 7 J Inorg Biochem, 98/11, 1722-1733.
10. Huq F (2005) A molecular modeling analysis of why the lower-membered alkanoic acids are infinitely soluble in water whereas the higher-membered ones have a very low solubility in water, Asian J Chem, Volume 17(2), 1001-1012.
11. Chowdhury A, Huq F, Abdullah A, Beale P, Fisher K (2005) Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the form: trans-PtL2Cl2 and PtL3Cl where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-a)pyridine, J Inorg Biochem, 99(5), 1098-1112.
12. Cheng H, Huq F, Beale P and Fisher K (2005) Synthesis, characterisation, activities, cell uptake and DNA binding of the trinuclear complex: [{trans-PtCl(NH3)}2m-{trans-Pt(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4, Eur J Med Chem, 40(8), 772-781.
13. Cheng H, Huq F and Farhad M (2005) Interaction between Cu2+ and the nucleobases adenine and guanine in solution in water, Asian J Chem, 18, 17(3), 1532-1538.
14. Huq F (2005) Molecular mechanics and semi-empirical analyses of the interaction between Cu2+and amino acids glycine, L-histidine and L-arginine in solution in water, Asian J Chem, 17(3), 1550-1558.
15. Huq F, Tayyem H, Abdullah A, Beale P and Fisher K (2006) Synthesis and characterization and binding of amine-palladium(II) complexes and their interaction with DNA, Asian J Chem, 18(1), 65-78.
16. Huq F and Peter MCR (2006) Molecular mechanics and semi-empirical analyses of the interaction between Ni2+ and amino acids L-histidine and L-arginine in solution in water, Asian J Chem, 18(1), 45-49.
17. Cheng H, Chowdhury A and Huq F (2006) Interaction between Ag+, and nucleobases and nucleotides in solution, Asian J Chem, 18(1), 37-44.
18. Huq F, Peter MCR (2006), Molecular mechanics and semi-empirical analyses of the interaction between Co2+ and the amino acids L-histidine and L-arginine in solution in water, Asian J Chem, 18(1), 79-85.
19. Huq F and Peter MCR (2006), Molecular modelling analysis of the interaction between Fe3+ and the amino acid L-cysteine in solution in water at low pH, Asian J Chem,18(1), 97-102.
20. Huq F, Abdullah A, Chowdhury A, Tayyem H, Beale P and Fisher K (2006) Studies on the synthesis and characterization, and binding with DNA of two cis-planaramineplatinum(II) complexes of the forms: cis-PtL2Cl2 and cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and imidazo(1,2-)pyridine respectively, Int J Pure and Appl Chem, 1(1), 91-100.
21. Huq F, Abdullah A, Chowdhury A, Cheng H, Tayyem H, and Beale P (2006), Studies on the synthesis and characterization , binding with DNA and activity of cis-bis{imidazo(1,2-)pyridine}dichloroplatinum(II), Asian J Chem, 18(3), 1637-1648.
22. Hossain Z and Huq F (2006) Vitamin C causes a much-pronounced damage to DNA in presence of Cd2+ but not in presence of Zn2+ or Ag+. Why?, Asian J Chem,18(3), 1649-1658.
23. Huq F, Farhad M, Abdullah A and Beale P (2006) Studies on oligonuclear palladium complexes, Asian Journal of Chemistry, 18(3), 1607-1625.
24. Huq F (2006) Molecular modelling analysis of the axial distortion of the coordination geometry around copper(II) in octahedral ligand fields, Asian J Chem,18(3), 1633-1636.
25. Abdullah A, Huq F, Chowdhury A, Tayyem H, Beale P (2006)  Studies on the Synthesis, Characterization, Binding with DNA and Activities of two cis-planaramineplatinum(II) complexes of the form: cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine, BMC Chem Biol, 6, 3, doi:10.1186/1472-6769-6-3; http://www.biomedcentral.com/1472-6769/6/3.
26. Huq F, Abdullah A and Beale P (2006), Antitumour Activity of cis-bis{imidazo(1,2-a)pyridineplatinum(II), Int J Cancer Res, 2(4): 367-375.
27. Cheng H, Huq F, Beale P and Fisher K (2006), Synthesis, characterisation, activities, cell uptake and DNA binding of the trinuclear complex: [{trans-PtCl(NH3)}2m-{trans-Pd(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4, Eur J Med Chem, 41: 896-903.
28. Huq F, Abdullah A, Beale P, Yu JQ and Zhang M (2006), Studies on the synthesis, characterization and binding with DNA of cis-PtL2I2 where L = 2,3-diaminopyridine: A compound with high cell uptake and drug-DNA binding but very little activity, Int J Pure and Appl Chem, 1(2): 205-211.
29. Huq F, Daghriri H, Yu JQ, Beale P and Fisher K (2006), Syntheses and characterisation of four trinuclear complexes of the form: [{trans-PtCl(NH3)2}2m-{trans-Pd(NH3)2(H2N(CH2)nNH2)2]Cl4 where n = 4 to 7, Int J Pure and Appl Chem, 1(4), 493-507.
30. Farhad M, Huq F and Sivanandasingham P (2006), In vitro studies on DNA damage due to mixtures of ascorbate and iron(II), Int J Pure and Appl Chem, 1(2): 197-203.
31. Huq F (2006), A molecular modelling analysis of why DDT and its metabolites have prolonged persistence in the environment and the living systems, Int J Pure and Appl Chem, 1(2): 191-196.
32. Huq F and Hossain Z (2006), Molecular modelling analysis of the metabolism of chloropromazine, Int J Pure and Appl Chem, 1(1), 15-21.
33. Huq F and Hossain Z (2006), Molecular modelling analysis of the metabolism of diazepam, Int J Pure and Appl Chem, 1(1), 23-29.
34. Huq F (2006), Molecular modelling analysis of the metabolism of dacarbazine, Int J Pure and Appl Chem, 1(1), 29-36.
35. Huq F (2006), Molecular modelling analysis of the metabolism of hydralazine, Int J Pure and Appl Chem, 1(1): 7-13.
36. Huq F (2006), Molecular modelling analysis of the metabolism of quazepam, Int J Pure and Appl Chem, 1(2): 141-146.
37. Huq F (2006), Molecular modelling analysis of the metabolism of tamoxifen, Int J Pure and Appl Chem, 1(2): 155-163.
38. Huq F (2006), Molecular modelling analysis of the metabolism of sulindac, Int J Pure and Appl Chem, 1(2): 165-169.
39. Huq F (2006), Molecular modelling analysis of the metabolism of nitroimidazoles, Int J Pure and Appl Chem, 1(2): 147-153.
40. Huq F (2006), Molecular modelling analysis of the metabolism of maprotiline, J Pharmacol & Toxicol, 1(6): 537-544.
41. Huq F and Hossain Z (2006), Molecular modelling analysis of the metabolism of pyrazinamide, J Pharmacol & Toxicol, 1(6): 505-515.
42. Huq F and Shuneigat J (2006), Molecular modelling analysis of the metabolism of codeine, J Pharmacol & Toxicol, 1(5): 407-417.
43. Huq F (2006), Molecular modelling analysis of the metabolism of isoniazid, J Pharmacol & Toxicol, 1(5): 447-455.
44. Huq F (2006), Molecular modelling analysis of the metabolism of chloroform, J Pharmacol & Toxicol, 1(5): 438-446.
45. Huq F (2006), Molecular modelling analysis of the metabolism of Adefovir Dipivoxil, J Pharmacol & Toxicol, 1(4): 362-368.
46. Huq F (2006), Molecular modelling analysis of the metabolism of zebularine, J Pharmacol & Toxicol, 1(4): 317-327.
47. Huq F (2006), Molecular modelling analysis of the metabolism of modafinil, J Pharmacol & Toxicol, 1(4), 369-375.
48. Huq F (2006), Molecular modelling analysis of the metabolism of naproxen, J Pharmacol & Toxicol, 1(4): 346-353.
49. Huq F (2006), Molecular modelling analysis of the metabolism of niclosamide, J Pharmacol & Toxicol, 1(4): 376-382.
50. Huq F (2006), Molecular modelling analysis of the metabolism of zaleplon, J Pharmacol & Toxicol, 1(4): 328-336.
51. Huq F (2006), Molecular modelling analysis of the metabolism of naltrexone, J Pharmacol & Toxicol, 1(4): 354-361.
52. Huq F (2006), Molecular modelling analysis of the metabolism of vinyl chloride, J Pharmacol & Toxicol, 1(4): 299-316.
53. Huq F (2006), Molecular modelling analysis of the metabolism of ibuprofen, J Pharmacol & Toxicol, 1(5): 456-463.
54. Huq F (2006), Molecular modelling analysis of the metabolism of caffeine, Asian J Biochem, 1(4): 276-286.
55. Huq F (2006), Molecular modelling analysis of the metabolism of letrozole, Int J Cancer Res, 2(4): 403-408.
56. Huq F (2006), Molecular modelling analysis of the metabolism of topotecan, Int J Cancer Res, 2(4): 390-396.
57. Huq F (2006), Molecular modelling analysis of the metabolism of enrofloxacin, Asian J Biochem, 1(4): 316-324.
58. Huq F (2006), Molecular modelling analysis of the metabolism of hydrazine, J Pharmacol & Toxicol, 1(5): 485-489.
59. Huq F (2006), Molecular modelling analysis of the metabolism of morphine, Int J Pure and Appl Chem, 1(3): 349-357.
60. Huq F (2006), Molecular modelling analysis of the metabolism of sildenafil, Int J Pure and Appl Chem, 1(3): 339-347.
61. Huq F (2006), Molecular modelling analysis of the metabolism of styrene, Int J Pure and Appl Chem, 1(3): 371-378.
62. Huq F and Alshehri A (2006), Molecular modelling analysis of the metabolism of diclofenac, Int J Pure and Appl Chem, 1(3): 359-370.
63. Huq F (2006), Metabolism of nicotine: a molecular modelling analysis, Int J Pure and Appl Chem, 1(3): 315-322.
64. Huq F (2006), Molecular modelling analysis of the metabolism of phenytoin, Int J Pure and Appl Chem, 1(3): 307-314.
65. Huq F (2006), Molecular modelling analysis of the metabolism of cocaine, Int J Pure and Appl Chem, 1(3): 323-330.
66. Huq F (2006), A molecular modelling analysis of caffeine and its metabolites, Int J Pure and Appl Chem, 1(3): 331-338.
67. Huq F and Ababneh D (2006), Semi-empirical and DFT analyses of the metabolic activation of ethylene glycol, Int J Pure and Appl Chem, 1(4), 477-483.
68. Huq F and Hossain Z (2006), Semi-empirical and DFT analyses of the metabolism of pyrazinamide, Int J Pure and Appl Chem, 1(4), 469-475.
69. Huq F (2006) Metabolic activation of naphthalene – a molecular modelling analysis, Int J Pure and Appl Chem, 1(4), 485-402.
70. Huq F (2006), Molecular modelling analysis of the metabolism of benzene, Int J Pure and Appl Chem, 1(4), 461-467.
71. Huq F (2007), Semi-empirical and DFT analyses of the metabolism of hydrazine, Int J Pure and Appl Chem, 1(4): 455-459.
72. Huq F, Tayyem H, Abdullah A and Beale P (2007) Anticancer activity, cell uptake and level of binding with DNA of three palladium(II) compounds of the form: trans-PdL2Cl2 where L = 2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine, against human ovarian cancer cell lines, J Inorg Biochem, 101: 30-35.
73. Huq F (2007), Molecular modelling analysis of the dimerization of acetic acid in non-polar solvents, Asian J Chem, 19(1), 27-33.
74. Huq F (2007), A molecular modelling analysis of the relative stability of alkenes and arenes, the resulting epoxides and diols, Asian J Chem,19(1), 39-48.
75. Huq F (2007), Molecular modelling analysis of the ortho-, para- and meta-directing influences of substituents in electrophilic attack on aromatic compounds, Asian J Chem,19(1), 55-56.
76. Huq F (2007), The structure of hexakis(trimethylsilylmethyl)dimolybdenum: the first compound reported to have a MoºMo bond, Fazlul Huq, Asian J Chem,19(1), 49-54.
77. Huq F and Ababneh D (2007), Molecular modelling analysis of the metabolic activation of ethylene glycol, J Pharmacol & Toxicol, 2(1): 54-62.
78. Huq F (2007), Molecular modelling analysis of the metabolism of aspirin, Asian J Chem, 19(1), 102-108.
79. Huq F (2007), Molecular modelling analysis of the metabolism of mefenamic acid, J Pharmacol & Toxicol, 2(1): 72-79.
80. Huq F (2007), Molecular modelling analysis of the metabolism of naphthalene, J Pharmacol & Toxicol, 2(1): 33-43.
81. Huq F (2007), Molecular modelling analysis of the metabolism of phenytoin, J Pharmacol & Toxicol, 2(1): 63-71.
82. Huq F (2007), Molecular modelling analysis of the metabolism of toluene, J Pharmacol & Toxicol, 2(1): 20-32.
83. Huq F and Jehad Al-Shuneigat (2007), Molecular modelling analysis of the metabolism of methadone, Asian J Biochem, 2(1): 19-30
84. Huq F (2007), Molecular modelling analysis of the metabolism of fenbufen, Asian J Biochem, 2(1): 50-57.
85. Huq F (2007), Molecular modelling analysis of the metabolism of anagrelide, Int J Cancer Res, 3(1): 33-38.
86. Huq F (2007), Molecular modelling analysis of the metabolism of enoxacin, J Pharmacol & Toxicol, 2(3), 284-289.
87. Huq F (2007), Molecular modelling analysis of the metabolism of tolterodine, J Pharmacol & Toxicol, 2(4), 319-327.
88. Huq F (2007), Molecular modelling analysis of the metabolism of meropenem, J Pharmacol & Toxicol, 2(3), 295-299.
89. Huq F (2007), Molecular modelling analysis of the metabolism of paracetamol, J Pharmacol & Toxicol, 2(2), 142-150.
90. Huq F (2007), Molecular modelling analysis of the metabolism of cocaine, J Pharmacol & Toxicol, 2(2), 114-130.
91. Huq F (2007), Molecular modelling analysis of the metabolism of fentanyl, J Pharmacol & Toxicol, 2(2), 176-182.
92. Huq F (2007), Molecular modelling analysis of the metabolism of latanoprost, J Pharmacol & Toxicol, 2(4), 359-365.
93. Huq F (2007), Molecular modelling analysis of the metabolism of ceftiofur, J Pharmacol & Toxicol, 2(4), 340-349.
94. Huq F (2007), Molecular modelling analysis of the metabolism of irbesartan, J Pharmacol & Toxicol, 2(3), 238-247.
95. Huq F (2007), Molecular modelling analysis of the metabolism of aniracetam, Asian J. Biochem., 2(3): 164-171.
96. Huq F, Molecular modelling analysis of the metabolism of eszopiclone, J Pharmacol & Toxicol, 2007 (submitted on 24 March 2007 – 183: JPT – in the press).
97. Huq F (2007), Metabolism of isoniazid – a molecular modeling analysis, Int J Pure and Appl Chem, 2(1), 1-9.
98. Huq F (2007), Metabolism of vinyl chloride – a molecular modeling analysis, Int J Pure and Appl Chem, 2(1), 11-18.
99. Huq F (2007), Molecular modelling analysis of the formation of HX.H2O aggregates and (HX)n oligomers where X = F, Cl, Br, Int J Pure and Appl Chem, 2(1), 19-25.
100. Huq F (2007) Metabolic activation of paracetamol – a molecular modelling analysis, Int J Pure and Appl Chem, 2(1), 43-49.
101. Huq F (2007), Molecular modelling analysis of the metabolism of methamphetamine, Int J Pure and Appl Chem, 2(1), 27-35.
102. Huq F (2007), Metabolism of niclosamide – a molecular modelling analysis, Int J Pure and Appl Chem, 2(1), 77-83.
103. Huq F (2007), Molecular modelling analysis of the metabolism of carbon tetrachloride, Int J Pure and Appl Chem, 2(1), 85-91.
104. Huq F (2007), Metabolic activation of chloroform – a molecular modelling analysis, Int J Pure and Appl Chem, 2(1), 37-42.
105. Huq F (2007), Metabolic activation of toluene – a molecular modelling analysis, Int J Pure and Appl Chem, 2(1), 105-120.
106. Huq F (2007), Metabolism of mefenamic acid – a molecular modelling analysis, Int J Pure and Appl Chem, 2(1), 121-126.
107. Huq F (2007), Molecular modelling analysis of the metabolism of probucol, Asian Journal of Biochemistry, 2(5): 354-358.
108. Huq F (2007), Molecular modelling analysis of the metabolism of troglitazone, Asian Journal of Biochemistry, 2(4): 256-262.
109. Huq F (2007), Molecular modelling analysis of the metabolism of thiabendazole, J Pharmacol & Toxicol, 2(6): 524-532.
110. Huq F (2007), Molecular modelling analysis of the metabolism of tegaserod, J Pharmacol & Toxicol, 2(5): 447-455.
111. Huq F (2007), Molecular modelling analysis of the metabolism of clofarabine, J Pharmacol & Toxicol, 2(7): 599-609.
112. Huq F (2007), Molecular modelling analysis of the metabolism of fosamax and risedronate, J Pharmacol & Toxicol, 2(5): 489-495.
113. Huq F (2007), Molecular modelling analysis of the metabolism of luliconazole, J Pharmacol & Toxicol, 2(6): 567-573.
114. Huq F (2007), Molecular modelling analysis of the metabolism of mexiletine, J Pharmacol & Toxicol, 2(7): 638-645.

Accepted

115. Huq F (2007), Molecular modelling analysis of the metabolism of rasagiline, J Pharmacol & Toxicol, 2007 (157-JPT – accepted on 16 February 2007 – in press)
116. Huq F (2007), Molecular modelling analysis of the metabolism of zolpidem, J Pharmacol & Toxicol, (146-JPT – accepted on 9 March 2007 – in press)
117. Huq F (2007), Molecular modelling analysis of the metabolism of methimazole, J Pharmacol & Toxicol, (JPT: 168 – accepted on 15 March 2007 – in the press).
118. Huq F (2007), Molecular modelling analysis of the metabolism of venlafaxine, J Pharmacol & Toxicol, (167: JPT – accepted on 20 April 2007 – in press).
119. Huq F, Molecular modelling analysis of the metabolism of terbinafine, Journal of Pharmacology and Toxicology, (187-JPT – accepted on 25 April 2007 – in the press).
120. Huq F, Molecular modelling analysis of the metabolism of ambroxol, J Pharmacol & Toxicol, 2007 (180: JPT – accepted on 26 April 2007 – in the press).
121. Huq F, Molecular modelling analysis of the metabolism of entecavir, J Pharmacol & Toxicol, 2007 (182: JPT – accepted on 30 April 2007 – in press).
122. Huq F (2007), Molecular modelling analysis of the metabolism of clotrimazole, J Pharmacol & Toxicol, (accepted on 12 May 2006 – in press).
123. Huq F (2007), Molecular modelling analysis of the metabolism of nefazodone, Int J Pure and Appl Chem, (IJPAC-06-040 – accepted on 18 May 2007 for publication in volume 2(2)).
124. Huq F (2007), Molecular modelling analysis of the metabolism of RU486, Int J Pure and Appl Chem, (IJPAC 06-027 – accepted on 20 May 2007).
125. Huq F (2007), Ababneh D and Alshehri A, Molecular modelling analysis of the metabolism of carbamazepine, Int J Pure and Appl Chem, (IJPAC -06-030 – accepted on 22 May 2007).
126. Huq F, Molecular modelling analysis of the metabolism of loxapine, Int J Pure and Appl Chem, 2006 (submitted: IJPAC-06-042 – accepted on 3 June 2007).
127. Huq F and Shahnaz Al-qassab, Molecular modelling analysis of the metabolism of raloxifene, Int J Pure and Appl Chem, 2006 (submitted: IJPAC-06-054; accepted on 29 June 2007).
128. Huq F, Molecular modelling analysis of the metabolism of diflunisal, Int J Pure and Appl Chem, 2006 (submitted: IJPAC-06-045 - accepted).
129. Huq F, The crystal and molecular structure of tetrakis(trimethylsilylmethyl)bis--trimethylsilylmethylidynediniobium(V), Nb2(CH2SiMe3)4(CSiMe3)2, a compound containing a quasi-aromatic ring, Asian Journal of Chemistry, 2007 (submitted on 13 April 2007: AJC- 6724/2007 – accepted on 24 July 2007).
130. Huq F, Molecular modelling Huq F, Molecular modelling analysis of the metabolism of maraviroc, Asian Journal of Biochemistry, 2007 (submitted: 147-AJB - accepted).
131. Huq F, Molecular modelling analysis of the metabolism of udenafil, Asian Journal of Biochemistry, 2007 (submitted on 12 May 2007 – 136-AJB - accepted).
132. Huq F, Molecular modelling analysis of the metabolism of ketoprofen, Int J Pure and Appl Chem, 2006 (submitted: IJPAC-06-048 – accepted on 27 July 2007).

Dr. Huq’s Research Team

Dr. Huq’s current research team consists of postgraduate students listed below, research associate Dr. Jun Qing Yu, and honorary associates: Dr. Philip Beale and Dr. Dana Strain.

he following students work together with Dr. Fazlul Huq

Higher Degree Completions:

For more information:

TOP OF PAGE